Home › Cardiovascular Disease › Tennessee
Cardiovascular Disease clinical trials in Tennessee
27 studies for Cardiovascular Disease are looking for participants at sites in Tennessee.
Cities in Tennessee
ELEVATE-HFpEF Clinical Study
- Saint Thomas Research Institute, Nashville
Recruiting
Ages 40 and older · All sexes · Updated Oct 2, 2026 · NCT06678841Improving Veteran Referral to Cardiac Rehabilitation
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
Recruiting
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07079358EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Alliance for Multispecialty Research, LLC-Knoxville-69693, Knoxville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07064473Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- Stern Cardiovascular Center, Germantown
- Ballad Health System, Greeneville
- Apex Research Foundation, LLC, Jackson
- and 2 more
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06909565Product Surveillance Registry
- Germantown
- Memphis
- Nashville
RecruitingObservational study
All ages · All sexes · Updated Sep 18, 2026 · NCT01524276Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Chattanooga
- Clinical Trial Site, Chattanooga
- Clinical Trial Site, Knoxville
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07181109Zenith® Fenestrated+ Clinical Study
- Holston Valley Hospital, Kingsport
Recruiting
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT04875429Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
- Vanderbilt University Medical Center, Nashville
Recruiting
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT03242642Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- Baptist - Memphis (Stern), Memphis
Recruiting
Ages 18 to 100 · All sexes · Updated Sep 9, 2026 · NCT06310031An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- The Stern Cardiovascular Foundation, Germantown
- Apex Cardiology Research Associates of Jackson, Jackson
- Vanderbilt Univ Medi Cen, Nashville
- and 1 more
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Sep 4, 2026 · NCT07517263Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)
- Vanderbilt University Medical Center, Nashville
Recruiting
Ages 18 to 85 · All sexes · Updated Sep 3, 2026 · NCT06703489Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
- Meharry Medical College, Nashville
- Nashville VA Medical Center, Nashville
- Vanderbilt University Medical Center, Nashville
RecruitingPhase 4Healthy volunteers welcome
Ages 75 and older · All sexes · Updated Sep 1, 2026 · NCT04262206Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
- Vanderbilt University Medical Center, Nashville
RecruitingPhase 2
Ages 18 to 89 · All sexes · Updated Aug 27, 2026 · NCT05288790A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
- East Tennessee Childrens Hospital, Knoxville
RecruitingObservational study
Ages 7 and older · All sexes · Updated Aug 25, 2026 · NCT05705531A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Chattanooga
- Research Site, Chattanooga
- Research Site, Greeneville
- and 9 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07000357OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Erlanger Health, Inc., Chattanooga
- Ascension Saint Thomas, Nashville
- Parkway Cardiology Associates, Oak Ridge
- and 1 more
RecruitingPhase 3
Ages 50 to 105 · All sexes · Updated Aug 21, 2026 · NCT07136012Global Paradise System US Post Approval Study
- Ascension Saint Thomas, Nashville
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT06297291Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
- Novartis Investigative Site, Tullahoma
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Aug 7, 2026 · NCT06813911PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- Vanderbilt, Nashville
Recruiting
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT05934487Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- The Stern Cardiovascular Foundation, Memphis
Recruiting
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT06526195GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV
- Vanderbilt University Medical Center, Nashville
RecruitingPhase 2
Ages 18 to 89 · All sexes · Updated May 26, 2026 · NCT07221214Pivotal Study for the Cardiac Performance System (CPS)
- The Stern Cardiovascular Foundation, Inc. / Baptist Memorial Hospital, Germantown
RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 24, 2026 · NCT06870591The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- Centennial Medical Center, Nashville
Recruiting
Ages 18 and older · All sexes · Updated Apr 13, 2026 · NCT03142152Randomized Trial of SGLT2i in Heart Transplant Recipients
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Jan 22, 2026 · NCT06625073Gut Microbiota in Metabolic Surgery
- Vanderbilt_University MC, Nashville
RecruitingObservational study
Ages 21 to 65 · All sexes · Updated Nov 4, 2025 · NCT05000996MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
- Centennial Medical Center, Nashville
Recruiting
Ages 18 to 110 · All sexes · Updated Feb 25, 2025 · NCT05908331Multi-Center Study of Clinical and Inflammatory Outcomes in Intensive Cardiac Rehabilitation and Traditional Cardiac Rehabilitation Programs
- Ballad CVA Heart Institute, Kingsport
Recruiting
Ages 18 and older · All sexes · Updated May 21, 2024 · NCT06424119From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.